[go: up one dir, main page]

ZA200107523B - Method for improving the stability of stored and/or light-sensitive therapeutic systems or component thereof. - Google Patents

Method for improving the stability of stored and/or light-sensitive therapeutic systems or component thereof.

Info

Publication number
ZA200107523B
ZA200107523B ZA200107523A ZA200107523A ZA200107523B ZA 200107523 B ZA200107523 B ZA 200107523B ZA 200107523 A ZA200107523 A ZA 200107523A ZA 200107523 A ZA200107523 A ZA 200107523A ZA 200107523 B ZA200107523 B ZA 200107523B
Authority
ZA
South Africa
Prior art keywords
stability
improving
stored
light
component
Prior art date
Application number
ZA200107523A
Inventor
Achim Berthold
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of ZA200107523B publication Critical patent/ZA200107523B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA200107523A 1999-03-20 2001-09-12 Method for improving the stability of stored and/or light-sensitive therapeutic systems or component thereof. ZA200107523B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19912623A DE19912623A1 (en) 1999-03-20 1999-03-20 Process for increasing the stability when storing and / or using light-sensitive therapeutic systems or their components

Publications (1)

Publication Number Publication Date
ZA200107523B true ZA200107523B (en) 2002-11-27

Family

ID=7901787

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200107523A ZA200107523B (en) 1999-03-20 2001-09-12 Method for improving the stability of stored and/or light-sensitive therapeutic systems or component thereof.

Country Status (13)

Country Link
EP (1) EP1162957A1 (en)
JP (1) JP2002539238A (en)
KR (1) KR20010114231A (en)
CN (1) CN1343117A (en)
AR (1) AR023100A1 (en)
AU (1) AU771819B2 (en)
BR (1) BR0010516A (en)
CA (1) CA2366859A1 (en)
DE (1) DE19912623A1 (en)
HK (1) HK1039277A1 (en)
TR (1) TR200102604T2 (en)
WO (1) WO2000056289A1 (en)
ZA (1) ZA200107523B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10053375C1 (en) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermal therapeutic system with light-sensitive agent in polymer matrix and backing, useful for therapy with e.g. nicotine, nifedipine, lacidipine, gestagen, vitamin B 12 or antibiotic, contains colorless ultraviolet absorber
KR100704825B1 (en) 2003-02-21 2007-04-09 바이엘 쉐링 파마 악티엔게젤샤프트 ＵＶ Stability Transdermal Therapy Plaster
DE10317692A1 (en) 2003-04-17 2004-11-11 Lts Lohmann Therapie-Systeme Ag Medical active substance patches with reduced optical conspicuity on the skin
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
ATE451925T1 (en) * 2004-10-06 2010-01-15 Eisai R&D Man Co Ltd MEDICAL COMPOSITION, METHOD FOR PREPARATION THEREOF AND METHOD FOR STABILIZING A DIHYDROPYRIDINE COMPOUND IN A MEDICAL COMPOSITION
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
DE102010050242A1 (en) 2010-10-30 2012-05-03 Schott Ag Drug package for delivery of drugs, and for encapsulation and storage of fragrances and chemical indicators, comprises impermeable surface shaped cavity made of thin glass, where cavity is provided for containing active ingredient

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5832821A (en) * 1981-08-20 1983-02-25 Sumitomo Bakelite Co Ltd Light screening packaged material containing photodegradable medicine
DE3376198D1 (en) * 1983-11-30 1988-05-11 Siegfried Ag Therapeutic coronary composition in the form of soft gelatine capsules
JPS61293911A (en) * 1985-06-24 1986-12-24 Teisan Seiyaku Kk Sustained release preparation
JPH03145421A (en) * 1989-10-31 1991-06-20 Zeria Pharmaceut Co Ltd Stable eye drop
HUT59592A (en) * 1990-07-20 1992-06-29 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of solid medical products
US5268179A (en) * 1992-02-14 1993-12-07 Ciba-Geigy Corporation Ultrasonically sealed transdermal drug delivery systems
JPH07204251A (en) * 1993-10-15 1995-08-08 Dai Ichi Seiyaku Co Ltd Quinolon antibacterial preparations

Also Published As

Publication number Publication date
EP1162957A1 (en) 2001-12-19
AR023100A1 (en) 2002-09-04
CN1343117A (en) 2002-04-03
DE19912623A1 (en) 2000-09-28
BR0010516A (en) 2003-07-22
TR200102604T2 (en) 2002-01-21
KR20010114231A (en) 2001-12-31
AU771819B2 (en) 2004-04-01
HK1039277A1 (en) 2002-04-19
CA2366859A1 (en) 2000-09-28
JP2002539238A (en) 2002-11-19
AU3809100A (en) 2000-10-09
WO2000056289A1 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
PL366205A1 (en) Methods and systems for finding value and reducing risk
MXPA01011749A (en) Method of polymerization.
GB2352544B (en) Method and system for delivering integrated user assistance information and traditional help from the same source
GB9918348D0 (en) Location finding system and method
AU5334500A (en) Method and system for preventing the unauthorized use of software
AU6099100A (en) Ultra-rugged i.c. sensor and method of making the same
IL135360A0 (en) Dilation systems and related methods
PT936908E (en) UTERIC ANTICONVULSIVE DERIVATIVES IN THE TREATMENT OF AMIOTROPHIC LATERAL SCLEROSIS (ELA)
HUP0203746A3 (en) Novel composition and method for stabilizing the same
ZA200006996B (en) Method for the regenaration of sorbent materials.
ZA200201816B (en) A vaccine composition and method of using the same.
AU8661201A (en) Method, system and shoe enabling the determination of fit from outside of the shoe
EP1017980A4 (en) Methods of the identification of pharmaceutically active compounds
GB2352523B (en) Fluid-gauging systems and methods
AU1803401A (en) Methods and systems for generating tractograms
ZA200107523B (en) Method for improving the stability of stored and/or light-sensitive therapeutic systems or component thereof.
CY2362B1 (en) Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis.
ZA200110474B (en) Method and device for the continuous of NaAlCl4 or NaFeCl4.
ZA972708B (en) Pharmaceutical compositions and methods for the manufacture thereof.
EP0586848A3 (en) Implant.
AU1792200A (en) Use of phanquinone for the treatment or prevention of memory impairment
AU7609200A (en) Event based system for use within the creation and implementation of educationalsimulations
ZA200107591B (en) Transdermal therapy system and method for producing the same.
NO20011268D0 (en) Connection for the treatment of depression
MXPA01011318A (en) Integral telescoping vessel joint and method for using the same.